當(dāng)前位置：首頁(yè) JCRQ2 期刊介紹(非官網(wǎng))

Calcified Tissue InternationalSCIE

國(guó)際簡(jiǎn)稱：CALCIFIED TISSUE INT 參考譯名：鈣化組織國(guó)際

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q2

基本信息：: ISSN：0171-967X; E-ISSN：1432-0827; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Springer US; 出版語(yǔ)言：English; 出版周期：Monthly; 出版年份：1967; 研究方向：內(nèi)分泌學(xué)與代謝-醫(yī)學(xué)

評(píng)價(jià)信息：: 影響因子：3.3; H-index：106; CiteScore指數(shù)：8; SJR指數(shù)：1.016; SNIP指數(shù)：1.195

發(fā)文數(shù)據(jù)：: Gold OA文章占比：34.44%; 研究類文章占比：74.31%; 年發(fā)文量：109; 自引率：0.0238...; 開源占比：0.2985; 出版撤稿占比：0; 出版國(guó)人文章占比：0.09; OA被引用占比：0.2787...

投稿咨詢加急見刊

英文簡(jiǎn)介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問(wèn)題

英文簡(jiǎn)介Calcified Tissue International期刊介紹

Calcified Tissue International and Musculoskeletal Research publishes original research and reviews concerning the structure and function of bone, and other musculoskeletal tissues in living organisms and clinical studies of musculoskeletal disease. It includes studies of cell biology, molecular biology, intracellular signalling, and physiology, as well as research into the hormones, cytokines and other mediators that influence the musculoskeletal system. The journal also publishes clinical studies of relevance to bone disease, mineral metabolism, muscle function, and musculoskeletal interactions.

期刊簡(jiǎn)介Calcified Tissue International期刊介紹

《Calcified Tissue International》自1967出版以來(lái)，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺(tái)，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙?lái)某個(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：偏慢,4-8周
醫(yī)學(xué)
ENDOCRINOLOGY & METABOLISM
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Calcified Tissue International Cite Score數(shù)據(jù)

CiteScore：8
SJR：1.016
SNIP：1.195

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Orthopedics and Sports Medicine	Q1	18 / 321	94%
大類：Medicine 小類：Endocrinology, Diabetes and Metabolism	Q1	48 / 244	80%
大類：Medicine 小類：Endocrinology	Q1	29 / 128	77%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評(píng)價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫(kù)中收集的引文為基礎(chǔ)，針對(duì)的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評(píng)價(jià)期刊影響力的方法，而不僅僅是通過(guò)影響因子(IF)這一單一指標(biāo)來(lái)評(píng)價(jià)。

歷年Cite Score趨勢(shì)圖

中科院SCI分區(qū)Calcified Tissue International 中科院分區(qū)

中科院 2023年12月升級(jí)版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	ENDOCRINOLOGY & METABOLISM 內(nèi)分泌學(xué)與代謝	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對(duì)國(guó)際、國(guó)內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級(jí)劃分的期刊評(píng)價(jià)標(biāo)準(zhǔn)。它為我國(guó)科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評(píng)價(jià)國(guó)際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國(guó)各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評(píng)估。之后中科院分區(qū)逐步發(fā)展成為了一種評(píng)價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢(shì)圖

JCR分區(qū)Calcified Tissue International JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	77 / 186	58.9%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：ENDOCRINOLOGY & METABOLISM	SCIE	Q2	76 / 186	59.41%

JCR分區(qū)的優(yōu)勢(shì)在于它可以幫助讀者對(duì)學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評(píng)估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評(píng)價(jià)期刊的質(zhì)量可能是存在一定問(wèn)題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢(shì)圖

發(fā)文數(shù)據(jù)

2023-2024 年國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì)

國(guó)家/地區(qū)數(shù)量
USA91
CHINA MAINLAND62
England51
Australia49
Japan40
Italy39
France37
GERMANY (FED REP GER)31
Belgium24
Denmark23

本刊中國(guó)學(xué)者近年發(fā)表論文

1、Evaluation of Volumetric Bone Mineral Density, Bone Microarchitecture, and Bone Strength in Patients with Achondroplasia Caused by FGFR3 c.1138G > A Mutation
Author: Liang, Hanting; Qi, Wenting; Jin, Chenxi; Pang, Qianqian; Liu, Wei; Jiang, Yan; Wang, Ou; Li, Mei; Xing, Xiaoping; Pan, Hui; Xia, Weibo

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. 112, Issue 1, pp. 13-23. DOI: 10.1007/s00223-022-01027-2
2、lncRNA SERPINB9P1 Regulates SIRT6 Mediated Osteogenic Differentiation of BMSCs via miR-545-3p
Author: Wu, Min; Dai, Min; Liu, Xuqiang; Zeng, Qunqun; Lu, Yingjie

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. 112, Issue 1, pp. 92-102. DOI: 10.1007/s00223-022-01034-3
3、Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and the Risk of Fracture: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Author: Lv, Fang; Cai, Xiaoling; Lin, Chu; Yang, Wenjia; Hu, Suiyuan; Ji, Linong

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00223-023-01085-0
4、Asperosaponin VI Protects Against Bone Loss Due to Hindlimb Unloading in Skeletally Growing Mice Through Regulating Microbial Dysbiosis Altering the 5-HT Pathway
Author: Niu, Y. -B.; Zhang, Y. -H.; Sun, Y.; Song, X. -Z.; Li, Z. -H.; Xie, M.; Mei, Q. -B.; Li, Y. -H.; Chen, Q.

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00223-022-01057-w
5、Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Academique de Recherche et d'Experimentation en Sante (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging
Author: Ladang, Aurelie; Beaudart, Charlotte; Reginster, Jean-Yves; Al-Daghri, Nasser; Bruyere, Olivier; Burlet, Nansa; Cesari, Matteo; Cherubini, Antonio; da Silva, Mario Coelho; Cooper, Cyrus; Cruz-Jentoft, Alfonso J.; Landi, Francesco; Laslop, Andrea; Maggi, Stefania; Mobasheri, Ali; Ormarsdottir, Sif; Radermecker, Regis; Visser, Marjolein; Yerro, Maria Concepcion Prieto; Rizzoli, Rene; Cavalier, Etienne

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00223-022-01054-z
6、Extensive and Differential Deterioration of Hip Muscles May Preexist in Older Adults with Hip Fractures: Evidence from a Cross-Sectional Study
Author: Ling, Ming; Huang, Hou; Li, Xianlong; Xu, Yueyang; Fan, Yongqian

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s00223-022-01043-2
7、Metabolome-Wide Mendelian Randomization Assessing the Causal Relationship Between Blood Metabolites and Bone Mineral Density
Author: Chen, Shuhong; He, Weiman

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. 112, Issue 5, pp. 543-562. DOI: 10.1007/s00223-023-01069-0
8、Urotensin II can Induce Skeletal Muscle Atrophy Associated with Upregulating Ubiquitin-Proteasome System and Inhibiting the Differentiation of Satellite Cells in CRF Mice
Author: Pan, Yajing; Zhou, Ting; Dong, Xingtong; Wu, Leiyun; Wang, Peiwen; Wang, Shiyuan; Zhang, Aihua

Journal: CALCIFIED TISSUE INTERNATIONAL. 2023; Vol. 112, Issue 5, pp. 603-612. DOI: 10.1007/s00223-023-01073-4